Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Exp Neurol. 2008 Aug 28;214(2):253–258. doi: 10.1016/j.expneurol.2008.08.009

Figure 7.

Figure 7

Effect of LAU-0901 on local cerebral blood flow (LCBF). Basal indicated no MCAo. LAU-0901 (30 mg/kg; n=11) or vehicle (n=8) was administered IP at 1 h after onset of reperfusion. LCBF was reduced to 15% during MCAo in all animals and increased to 41% from baseline in vehicle-treated mice. In contrast, treatment with LAU-0901 increased LCBF to 77% at 6 h compared to vehicle-treated mice. Values shown are means ± SEM. *Significantly different from corresponding vehicle group (p <0.05).